|
Variable
|
Primary outcome group (n = 30)
|
Event-free group (n = 70)
|
p-value
|
|---|
|
LVOT VTI
|
8.0
|
8.5
|
0.039
|
|
Ejection fraction (%)
|
32.3
|
27.4
|
0.169
|
|
Doppler derived cardiac output (L/min)
|
2.29
|
2.44
|
0.217
|
|
Age, years
|
80.1 ± 11.3
|
70.7 ± 15.1
|
0.003
|
|
NYHA class (% in stage III or IV)
|
80%
|
48.60%
|
0.014
|
|
Hemoglobin, g/dL
|
12.7 ± 1.4
|
13.5 ± 2.2
|
0.030
|
|
Blood urea nitrogen, g/dL
|
33.8 ± 15.4
|
24.1 ± 12.5
|
0.001
|
|
GFR <60 ml/min
|
75.90%
|
53.10%
|
0.038
|
|
Pulmonary artery pressure, mmHg
|
53.0 ± 16.9
|
45.3 ± 12.6
|
0.019
|
- Primary outcome was met in 30 subjects (28 death and 2 LVADs); Event free subjects were those alive at one year of follow up from TTE and without requirement for mechanical circulatory support
- Abbrev: GFR glomerular filtration rate, LVOT VTI Left ventricular outflow tract velocity time integral, NYHA New York Heart Association
